S. Ktorza et al., CD34-POSITIVE EARLY HUMAN THYMOCYTES - T-CELL RECEPTOR AND CYTOKINE RECEPTOR GENE-EXPRESSION, European Journal of Immunology, 25(9), 1995, pp. 2471-2478
CD34, a stem cell marker, has been shown to be expressed on human CD3(
-)CD4(-)CD8(-) (triple-negative; TN) thymocytes. Phenotypic and functi
onal analyses suggest the following differentiation sequence: CD34(+)1
(-)3(-)4(-)8(-) --> CD34(+)1(+)3(-)4(+/-)8(-) --> CD34(-)1(+)3(-)4(+)8
(+/-) --> CD34(-)1(++)3(-)4(+)8(+). In this report, we examined cytoki
ne receptor gene expression on these subsets by reverse transcription-
polymerase chain reaction analysis (RT-PCR). We were able to detect in
terleukin-7 receptor (IL-7R), c-kit and IL-2R gamma in all CD34(+) thy
mocyte subsets, consistent with previous functional studies. We found
IL-1R, granulocyte/macrophage colony-stimulating factor receptor-alpha
and IL-LCR transcripts in CD3(-) and CD34(+) subsets. Secondly, we in
vestigated T cell receptor (TCR)-delta and -beta gene rearrangement an
d transcription in CD34(+) thymocytes. Our results show that a full-le
ngth TCR-delta transcript and the recombination activating genes RAG-1
and RAG-2 mRNA were already expressed in the CD34(+)1(-) subset. Matu
re V beta-containing TCR transcripts were also detected in the CD34(+)
1(+) subset: but not in the CD1(-) fraction. Furthermore, PCR analysis
of D-J beta gene rearrangements showed that greater than or equal to
70% of CD34(+)1(-) cells are in a TCR beta germ-line configuration, al
though D-J beta recombination had already started in this population.